19 June 2013
Keywords: fda, panel, reviews, lymerix, safety, food, drug
Article | 01 February 2001
A US Food and Drug Administration advisory panel has reviewed the safetyof GlaxoSmithKline's lyme disease vaccine LYMErix, which has been ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 February 2001
31 January 2001
© 2013 thepharmaletter.com